Physician profile
Kevin J Crable
NPI 1891109278
$3,062.95
in general payments reported to CMS, 2019-2025
24 companies · $596 in 2025
The $596 reported for 2025 was more than what 76% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $545 · 2020: $171 · 2021: $203 · 2022: $410 · 2023: $561 · 2024: $577 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,733.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $420.40 | 2021-2024 | Hydrofera Blue, Cutimed Sorbact |
| Abbvie INC. | $320.54 | 2021-2024 | Dalvance |
| Smith+Nephew, INC. | $308.01 | 2019-2025 | Collagenase Santyl, Renasys Touch, Regranex |
| Treace Medical Concepts, INC. | $259.55 | 2023-2025 | |
| Paratek Pharmaceuticals, INC. | $236.75 | 2021-2025 | Nuzyra |
| Aroa Biosurgery Incorporated | $228.18 | 2019-2023 | |
| Organogenesis INC. | $179.33 | 2023-2025 | Apligraf, Puraply, Puraply Am |
| Medela LLC | $165.57 | 2019-2022 | |
| Advanced Oxygen Therapy INC. | $145.60 | 2019-2020 | |
| Bsn Medical INC | $112.91 | 2024-2025 | |
| Kci USA, INC. | $106.13 | 2019 | |
| Lifenet Health | $92.73 | 2025 | Theragenesis Wound Matrix |
| Convatec INC. | $74.95 | 2022-2023 | |
| Mimedx Group, INC. | $73.39 | 2024-2025 | |
| Tactile Systems Technology INC | $55.51 | 2025 | Nimbl, Flexitouch Plus |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $53.19 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Ibsa Pharma INC. | $46.58 | 2023-2024 | Tirosint, Tirosint, Licart |
| Allergan, INC. | $43.87 | 2020 | |
| Integra Lifesciences Corporation | $39.49 | 2020-2021 | |
| Musculoskeletal Transplant Foundation INC. | $34.79 | 2021-2023 | |
| Amgen INC. | $23.04 | 2025 | Krystexxa |
| Ani Pharmaceuticals, INC. | $15.80 | 2025 | Purified Cortrophin Gel |
| Fidia Pharma USA INC. | $15.48 | 2019 | |
| Merck Sharp & Dohme LLC | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Crable listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.